Active Shortage Tablet Psychiatry

Amphetamine Aspartate Monohy · #22 of 35 active shortages by FDA posting duration

Brand: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

FDA lists Amphetamine Aspartate Monohy as Active Shortage (Aurobindo Pharma USA).

Availability on file: Unavailable

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: Active Shortage

Unavailable 73 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Manufacturer
Aurobindo Pharma USA
Dosage Form
Tablet
Presentation
Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)
Package NDC
13107-070-01

Status & Timeline

Status
Active Shortage
Availability
Unavailable
First Reported
Oct 12, 2022
Last Updated
Oct 15, 2025
Therapeutic Category
Psychiatry

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Estimated availability February 2026

Full Drug Profile

amphetamine/dextroamphetamine

Side effects, interactions, warnings & more

View Profile

Nearby, Other Amphetamine Shortage Records

FDA reason on file: Estimated availability February 2026. General shortage guidance lives on the tracker hub.